The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders - PubMed (original) (raw)

. 1995 Sep;242(9):579-86.

doi: 10.1007/BF00868810.

Affiliations

• PMID: 8551319
• DOI: 10.1007/BF00868810

The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders

P R Talbot et al. J Neurol. 1995 Sep.

Abstract

The accurate clinical diagnosis of degenerative cortical brain disorders is a necessary prerequisite for patient management and the critical evaluation of new treatments. This study has evaluated the ability of single photon emission tomography (SPET) to differentiate between Alzheimer's disease (AD) and different forms of non-Alzheimer lobar atrophy (LA), using a multi-purpose system in widespread routine clinical use. 99mTc-HMPAO SPET was carried out in patients with AD and three clinical syndromes associated with LA: frontotemporal dementia (FTD), progressive non-fluent aphasia (PA) and semantic dementia (SD). Principal component (PC) analysis was performed on regional cerebral blood flow (rCBF) data and inter-group comparisons were performed for PC scores using multiple t-tests. Three PCs explained 86.5% of the variation in rCBF values between individual patients and normal controls. The first PC reflected the average rCBF value and separated patient groups from normal controls but failed to distinguish between patient groups. The second PC reflected anterior-posterior asymmetry and separated AD from all three forms of LA. This PC also separated FTD and SD from controls but failed to distinguish between FTD, PA and SD. The third PC reflected left-right asymmetry and separated PA from all other groups. 99mTc-HMPAO SPET is able to differentiate between degenerative cortical brain disorders in a simple and physiological meaningful way, thereby showing considerable potential as a routine tool in the clinical evaluation and differentiation of AD and LA.

PubMed Disclaimer

Similar articles

• Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio.
  Sjögren M, Gustafson L, Wikkelsö C, Wallin A. Sjögren M, et al. Dement Geriatr Cogn Disord. 2000 Sep-Oct;11(5):275-85. doi: 10.1159/000017250. Dement Geriatr Cogn Disord. 2000. PMID: 10940679 Clinical Trial.
• Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
  Varma AR, Adams W, Lloyd JJ, Carson KJ, Snowden JS, Testa HJ, Jackson A, Neary D. Varma AR, et al. Acta Neurol Scand. 2002 Apr;105(4):261-9. doi: 10.1034/j.1600-0404.2002.1o148.x. Acta Neurol Scand. 2002. PMID: 11939938
• Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
  Varrone A, Pappatà S, Caracò C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M. Varrone A, et al. Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1447-54. doi: 10.1007/s00259-002-0883-5. Epub 2002 Aug 28. Eur J Nucl Med Mol Imaging. 2002. PMID: 12397463 Clinical Trial.
• [Neuropsychological and scintigraphic aspects of frontotemporal dementia preceding amyotrophic lateral sclerosis].
  Vercelletto M, Belliard S, Wiertlewski S, Venisse T, Magne C, Duyckaerts C, Damier P. Vercelletto M, et al. Rev Neurol (Paris). 2003 May;159(5 Pt 1):529-42. Rev Neurol (Paris). 2003. PMID: 12773898 Review. French.
• [Semantic dementia].
  Belliard S, Bon L, LeMoal S, Jonin PY, Vercelletto M, LeBail B. Belliard S, et al. Psychol Neuropsychiatr Vieil. 2007 Jun;5(2):127-38. Psychol Neuropsychiatr Vieil. 2007. PMID: 17556219 Review. French.

Cited by

• The effect of aperiodic components in distinguishing Alzheimer's disease from frontotemporal dementia.
  Wang Z, Liu A, Yu J, Wang P, Bi Y, Xue S, Zhang J, Guo H, Zhang W. Wang Z, et al. Geroscience. 2024 Feb;46(1):751-768. doi: 10.1007/s11357-023-01041-8. Epub 2023 Dec 19. Geroscience. 2024. PMID: 38110590 Free PMC article.
• Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer's disease.
  Thompson JC, Stopford CL, Snowden JS, Neary D. Thompson JC, et al. J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):920-7. doi: 10.1136/jnnp.2003.033779. J Neurol Neurosurg Psychiatry. 2005. PMID: 15965196 Free PMC article.
• FTD spectrum: Neuroimaging across the FTD spectrum.
  Whitwell JL. Whitwell JL. Prog Mol Biol Transl Sci. 2019;165:187-223. doi: 10.1016/bs.pmbts.2019.05.009. Epub 2019 Jun 18. Prog Mol Biol Transl Sci. 2019. PMID: 31481163 Free PMC article. Review.
• The dementing disorders.
  Hendrie HC, Unverzagt FW, Austrom MG. Hendrie HC, et al. Psychiatr Q. 1997 Fall;68(3):261-79. doi: 10.1023/a:1025488324153. Psychiatr Q. 1997. PMID: 9237320 Review.
• Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia.
  Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, Neary D. Varma AR, et al. J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):184-8. doi: 10.1136/jnnp.66.2.184. J Neurol Neurosurg Psychiatry. 1999. PMID: 10071097 Free PMC article.

References

1. 1. J Neurol Neurosurg Psychiatry. 1990 Jan;53(1):33-8 - PubMed
2. 1. J Am Geriatr Soc. 1986 Jan;34(1):12-9 - PubMed
3. 1. J Neurol Neurosurg Psychiatry. 1990 Nov;53(11):987-93 - PubMed
4. 1. Ann Neurol. 1982 Jun;11(6):592-8 - PubMed
5. 1. Brain. 1990 Oct;113 ( Pt 5):1395-404 - PubMed

MeSH terms

LinkOut - more resources

• Medical

  • MedlinePlus Health Information